Product Information
SACUBITRIL-VALSARTAN 97-103 MG is a generic product labeled by Major Pharmaceuticals, priced at $0.5932 per EA under NDC 00904758104. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on Sep 16, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Sacubitril and Valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
97; 103 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904758104
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SACUBITRIL; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA213764FDA Approved
9/16/2024
TE Code
AB
On Market Since
11/3/2025
Pharmacological Classes
Price Statistics
The NADAC for SACUBITRIL-VALSARTAN 97-103 MG has been published 26 times since Feb 25, 2026, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5932 per EA |
|---|---|
| All-time high | $0.6963 (Mar 11, 2026) |
| All-time low | $0.5796 (Jul 22, 2026) |
| 52-week high | $0.6963 |
| 52-week low | $0.5796 |
| Median price | $0.6084 |
| Average price | $0.6230 |
| Largest weekly change | -4.9% (Apr 22, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SACUBITRIL-VALSARTAN 97-103 MG?
The current National Average Drug Acquisition Cost (NADAC) for SACUBITRIL-VALSARTAN 97-103 MG, manufactured by Major Pharmaceuticals, is $0.5932 per EA (NDC 00904758104), effective Aug 19, 2026.
How has the price of SACUBITRIL-VALSARTAN 97-103 MG changed over time?
Over the history we have for it, the NADAC for SACUBITRIL-VALSARTAN 97-103 MG has declined 14.8%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for SACUBITRIL-VALSARTAN 97-103 MG?
Since Feb 25, 2026, the NADAC for SACUBITRIL-VALSARTAN 97-103 MG has ranged from a low of $0.5796 (Jul 22, 2026) to a high of $0.6963 (Mar 11, 2026), with a median of $0.6084 per EA.
Are there cheaper alternatives to SACUBITRIL-VALSARTAN 97-103 MG?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SACUBITRIL-VALSARTAN 97-103 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures SACUBITRIL-VALSARTAN 97-103 MG?
SACUBITRIL-VALSARTAN 97-103 MG (NDC 00904758104) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.